Catalent Inc
Company Profile
Business description
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Contact
14 Schoolhouse Road
SomersetNJ08873
USAT: +1 732 537-6200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
16,900
Catalent Inc News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,634.60 | 67.60 | 0.79% |
CAC 40 | 7,213.32 | 14.87 | 0.21% |
DAX 40 | 19,146.17 | 141.39 | 0.74% |
Dow JONES (US) | 43,870.35 | 461.88 | 1.06% |
FTSE 100 | 8,149.27 | 64.20 | 0.79% |
HKSE | 19,601.11 | 103.90 | -0.53% |
NASDAQ | 18,972.42 | 6.28 | 0.03% |
Nikkei 225 | 38,187.05 | 160.88 | 0.42% |
NZX 50 Index | 12,918.97 | 153.73 | 1.20% |
S&P 500 | 5,948.71 | 31.60 | 0.53% |
S&P/ASX 200 | 8,391.50 | 68.50 | 0.82% |